Cite
Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol.
MLA
Padrela, Beatriz, et al. “Developing Blood-Brain Barrier Arterial Spin Labelling as a Non-Invasive Early Biomarker of Alzheimer’s Disease (DEBBIE-AD): A Prospective Observational Multicohort Study Protocol.” BMJ Open, vol. 14, no. 3, Mar. 2024, p. e081635. EBSCOhost, https://doi.org/10.1136/bmjopen-2023-081635.
APA
Padrela, B., Mahroo, A., Tee, M., Sneve, M. H., Moyaert, P., Geier, O., Kuijer, J. P. A., Beun, S., Nordhøy, W., Zhu, Y. D., Buck, M. A., Hoinkiss, D. C., Konstandin, S., Huber, J., Wiersinga, J., Rikken, R., de Leeuw, D., Grydeland, H., Tippett, L., … Mutsaerts, H. J. M. M. (2024). Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol. BMJ Open, 14(3), e081635. https://doi.org/10.1136/bmjopen-2023-081635
Chicago
Padrela, Beatriz, Amnah Mahroo, Mervin Tee, Markus H Sneve, Paulien Moyaert, Oliver Geier, Joost P A Kuijer, et al. 2024. “Developing Blood-Brain Barrier Arterial Spin Labelling as a Non-Invasive Early Biomarker of Alzheimer’s Disease (DEBBIE-AD): A Prospective Observational Multicohort Study Protocol.” BMJ Open 14 (3): e081635. doi:10.1136/bmjopen-2023-081635.